Relaxations to oestrogen receptor subtype selective agonists in rat and mouse arteries

被引:20
作者
Al Zubair, K [1 ]
Razak, A [1 ]
Bexis, S [1 ]
Docherty, JR [1 ]
机构
[1] Royal Coll Surgeons Ireland, Dept Physiol, Dublin 2, Ireland
关键词
oestrogen receptor alpha; oestrogen receptor beta; oestrogen receptor; PPT (4,4 ',4 ''-(4-propyl-[1H]-pyrazole-1,3,5-triyl) tris-phenol); DPN (2,3-bis(4-hydroxyphenyl)-propionitrile); mouse aorta; mouse mesenteric artery;
D O I
10.1016/j.ejphar.2005.03.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been recently reported that the oestrogen receptor a agonist PPT (4,4 ',4 ''-(4-propyl-[1H]-pyrazole-1,3,5-triyl) tris-phenol) is more potent than the oestrogen receptor agonist DPN (2,3-bis(4-hydroxyphenyl)-propionitrile) at producing relaxations in rat mesenteric artery. We have investigated the relaxant actions of PPT and DPN in rat and mouse aorta and mesenteric artery. In rat aortic rings contracted with KCl (40 mM), the oestrogen receptor beta agonist DPN produced significantly greater relaxations than the oestrogen receptor alpha agonist PPT. In wild-type (WT) mouse aorta, the same result was found, but in WT mouse mesenteric artery, as in rat mesenteric artery, DPN was significantly less potent than PPT in females but had similar potency to PPT in males. Relaxations to DPN also occurred in aorta from nitric oxide synthase-3 -knockout (NOS-3-KO) mice, and in denuded aorta from both mouse and rat. Hence, in the mouse mesenteric artery, as in the rat mesenteric artery, PPT is at least as potent as DPN at producing relaxations; however, DPN was much more potent than PPT in the rat and mouse aorta. Effects of oestrogen receptor subtype selective agonists are tissue dependent. In addition, actions are largely endothelium-independent. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 45 条
[1]  
ALZUBAIR K, 2004, RELAXATIONS OESTROGE
[2]   Effect of acute and long-term treatment with 17-β-estradiol on the vasomotor responses in the rat aorta [J].
Andersen, HL ;
Weis, JU ;
Fjalland, B ;
Korsgaard, N .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (01) :159-168
[3]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[4]   Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice [J].
Bexis, S ;
Vandeputte, C ;
McCormick, PA ;
Docherty, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 499 (03) :325-333
[5]  
Brouchet L, 2001, CIRCULATION, V103, P423
[6]  
Brown TS, 1999, BT TELECOMM, V17, P291
[7]   17-β-oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism [J].
Bucci, M ;
Roviezzo, F ;
Cicala, C ;
Pinto, A ;
Cirino, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) :1695-1700
[8]   Antagonistic effects of 17β-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction [J].
Crews, JK ;
Khalil, RA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :1034-1040
[9]   Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor [J].
Darblade, B ;
Pendaries, C ;
Krust, A ;
Dupont, S ;
Fouque, MJ ;
Rami, J ;
Chambon, P ;
Bayard, F ;
Arnal, JF .
CIRCULATION RESEARCH, 2002, 90 (04) :413-419
[10]   The vascular protective effects of estrogen [J].
Farhat, MY ;
Lavigne, MC ;
Ramwell, PW .
FASEB JOURNAL, 1996, 10 (05) :615-624